Jan 20, 2020

Surgery, dose-escalated chemoradiotherapy yield similar outcomes in NSCLC | MDedge Hematology and Oncology

Key clinical point: After a complex induction protocol, patients with non–small cell lung cancer (NSCLC) who underwent surgery vs. dose-escalated chemoradiotherapy had similar 5-year overall survival rates.

Proceed to the page: http://linkis.com/FjbQN

Similar Articles Added Earlier

Similar Articles Added Today

Most Recent mdedge.com Articles

Latest Links Processed